期刊文献+

绝经期激素补充治疗对血清E_2、血脂及子宫内膜的影响

The Influence of Human Supplementary Menopausal Hormonotherapy on Serum E2, Blood-lipid and Endometrium
下载PDF
导出
摘要 目的 :观察不同绝经年限妇女激素补充治疗 (HRT)对血清E2 、血脂及子宫内膜的影响。方法 :对 38例绝经1~ 5年和 30例绝经 5年以上妇女连续联合使用激素补充治疗半年 ,用药前后观察绝经期症状、血清E2 、血脂四项、子宫内膜厚度及内膜细胞形态变化。结果 :用药后两组之绝经期症状均明显改善 ,Kupperman评分显著下降 ;用药后E2 均显著升高 (P <0 .0 1 ) ,FSH显著下降 (P <0 .0 5 ) ;绝经 1~ 5年组总胆固醇 (CHOL)、甘油三酯 (TG)、低密度脂蛋白 (LDL)均显著下降 ,高密度脂蛋白 (HDL)显著上升 ;而绝经 5年以上组用药后CHOL、LDL有所下降 ,而TG、HDL有升高趋势 ,但差异无统计学意义。两组HRT后子宫内膜均较HRT前增厚 ,1~ 5年组以混合型及增殖期型比例为主 ,而 5年以上组以萎缩型为主。内膜 >5mm者 ,1~ 5年组以增殖期型及伴分泌象为主 ,而 5年以上组以增殖期型为主。 1~ 5年组非计划性出血率高于 5年以上组。结论 :不同绝经年限妇女使用激素补充治疗(HRT)均能显著改善绝经期症状 ,但在血脂代谢及对子宫内膜的影响上却存在差异 ,使用HRT时宜根据绝经年限。 Objective:The influence of human supplementary menopausal hormonotherapy on serum E2,blood-lipid and endometrium of the women of different ages was observed.Methods:38 cases of menopause from one to five years and 30 cases of menopause for more than five years were used human supplementary menopausal hormonotherapy for half a year.Before and after the administration,the climacteric symptom,serum E2,the depth of endometrium as well as the changes of cell shape in tunica intima were observed.Results:After the administration,the climacteric symptom of the above two groups had been obviously improved.The Kupperman evaluation had been obviously decreased.E2 was significantly raised ( P <0.01) and FSH was significantly decreased ( P <0.05).Conclusion:The use of supplementary menopausal hormonotherapy at different menopauses can significantly improve the climacteric symptom,but as far as blood-lipid metabolism and the influence on endometrium are concerned,there exist differences.The use of supplementary menopausal hormonotherapy should be used according to the time of menopause and the purpose of treatment.
作者 王永霞 曹茵
出处 《赣南医学院学报》 2004年第4期378-380,共3页 JOURNAL OF GANNAN MEDICAL UNIVERSITY
关键词 激素补充治疗 血脂 子宫内膜 supplementary hormonotherapy serum endometrium
  • 相关文献

参考文献3

二级参考文献20

  • 1王抒,李健斋,赵淑华,唐蔚青,褚德发,李培瑛,满咏,李红霞.血清载脂蛋白参考值[J].中华医学检验杂志,1996,19(6):343-348. 被引量:30
  • 2吕文佩 郑淑蓉 杨欣.激素替代治疗对更年期症状的治疗作用[J].中华妇产科杂志,1997,32(10):563-563.
  • 3Omodd U, Ferrazzia E, Rugged C, et al. Endometrial thickness and histological abnormalities in women on hm-monal replacement therapy: a transvaginal ultrasound/hysteroscopic study. Ultrasound Obstet Gynecol,2000,15(4) :317 - 320.
  • 4Woodruff J, Pickar J. Incidence of endometrial hyperplasia in postmenopausal women tacking conjugated estrogens with medroxyprogesterone acetate or estrogexts alone. Am J Obstet Gynecol, 1994,170(5Ptl): 1213- 1223.
  • 5Pickar J, Archer D. Is bleeding a predictor of endometrial hyperplasia in postmenopausal women ~ceiving hormone replacement therapy? Am J Obstet Gynecol, 1997,177(5):1178 - 1183.
  • 6Stovall TG, Photopulos GL, Poston WM, et al. Pipelle endometrial sampling sensitivity in the detection of endometrial cancer. J Reprod Med,1995,40(11):553 - 555.
  • 7Pasqualotto EB, Margossian H, Price LL, et al. Accuracy d preoperadive agnostic tools and ontcome of hysteroscopic management of menstrual dysfunction. J Am Assoc Gynecol Laparosc, 2000, 7(2): 201-209.
  • 8Cameron ST, Walker J, Chambers S, et al. Comparison of transvaginal ultrasound, saline infusion sonography and hysteroscopy to investigate postmenopansal bleeding and unscheduled bleeding on HRT. Aust N Z J Obstet Gvnaecol, 2001 ,41 (3) :291 - 294.
  • 9周序四,中华妇产科杂志,1989年,24卷,89页
  • 10陈志龙,子宫内膜组织病理学(译),1984年,79,222页

共引文献49

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部